Dr. Reddy’s Laboratories has announced the appointment of cricket legend Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign. The brand had launched a teaser on social media and announced the appointment through a statement on August 17, 2023.
The campaign aims to raise awareness about hypertension, its symptoms, causes, and advocate the need for effectively managing blood pressure for a healthier life.
The #TensionMatLo campaign seeks to prompt the audience to pause, contemplate, and question the significance of managing blood pressure, informed an official statement. It will address the underlying causes of hypertension and emphasise the importance of regular blood pressure checks.
“I am happy to be associated with the #TensionMatLo campaign of Dr. Reddy’s. As a sportsperson, I understand the significance of maintaining good health for optimal performance. I am excited to contribute to the purpose of increasing awareness about this critical medical issue because I believe that uncontrolled blood pressure levels pave the way for many complications, some of which are life-threatening,” said Gavaskar.
MV Ramana, CEO – Branded Markets (India & Emerging Markets), Dr. Reddy’s, said, “Hypertension has been an important focus area for us. For over 30 years, we have served patients in this area through our robust portfolio. With this campaign and our partnership with Sunil Gavaskar, we aim to build further awareness and send out strong messages on the alarming spike in hypertension cases in India and the need to control it. Sunil Gavaskar represents the values we stand for. We are certain that his collaboration will help us reach a larger audience and educate them on hypertension control and management, thereby, meeting our patient-centric goals of accelerating accessibility to affordable and innovative medicines.”
The statement noted that with over 75 pc of Indians having uncontrolled blood pressure and being unaware of the hike in blood pressure, the Government of India launched the Indian Hypertension Control Initiative (IHCI) to fast-track access to treatment services for over 220 million people in India.
The collaboration marks a significant milestone in raising awareness about hypertension and empowering individuals to lead healthier lives, it added.
Feedback: [email protected]
